Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > As s1i has highlighted several times here

<< Previous

Bullboard Posts

Next >>

Comment by subaru1ion Nov 07, 2023 11:49am

84 Views

Post# 35721626

RE:RE:As s1i has highlighted several times here

Your commentary on the new 2023 agreement between LABS and Avicanna are incorrect. The PR from AVCN clearly stated: 1) expanded strategic manufacturing agreement (higher volumes? more sku's? or both?) 2) Technology integration of SEDDS for AVCN as well as for LABS.

So in summary, it is not at all "just a continuity of the agreement of 2020". Expanded and with new technology.

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment